Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

3.46
Real-Time Quote
 +0.015 / +0.44%
Today’s Change
3.16
Today|||52-Week Range
5.60
-11.18%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$322.0M

Company Description

Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. Its drug candidates also include Oral Glucocerebrosidase for potential treatment of Gaucher disease; therapeutic proteins for Fabry disease, and immune diseases such as rheumatoid, psoriatic and juvenile idiopathic arthritis, ankylosing, spondylitis, and plaque psoriasis; and protein for biodefense and other indications. The company was founded on November 30, 1995 and is headquartered in Carmiel, Israel.

Contact Information

Protalix Biotherapeutics, Inc.
2 Snunit Street
Carmiel -- 20100
P:(724) 988-9488
Investor Relations:

Employees

Shareholders

Mutual fund holders24.73%
Individual stakeholders15.56%
Other institutional14.11%

Top Executives

David AviezerPresident, Chief Executive Officer & Director
Tzvi PalashChief Operating Officer
Yossi MaimonCFO, Secretary, Treasurer, VP & Accounting Officer
Yoseph ShaaltielDirector, EVP-Research & Development
Moshe ChechikVice President-Engineering

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.